Dimethylamine

Dimethylamine

SCHEMBL7142653

CC(C)(C)NS(=O)(=O)c1cccc(S(=O)(=O)O)c1.CNC

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.70
MAPT P10636 2/20 0.70
KDM4E B2RXH2 2/20 0.70
MEN1 O00255 1/20 0.70
NPC1 O15118 1/20 0.70
LMNA P02545 1/20 0.70
HPGD P15428 1/20 0.70
RAB9A P51151 1/20 0.70
KMT2A Q03164 1/20 0.70
PARG Q86W56 2/20 0.50
ALDH1A1 P00352 6/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
JAK2 O60674 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.43
KIF18A Q8NI77 3/20 0.42
NSD2 O96028 2/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL7612044 1.00 SMN1; SMN2 (0.70) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL27435146 0.97 SMN1; SMN2 (0.74) SMN1; SMN2MAPTKDM4EMEN1NPC1
Methylamine SCHEMBL7145892 0.93 SMN1; SMN2 (0.70) SMN1; SMN2MAPTKDM4EMEN1NPC1
Dimethylamine SCHEMBL8501482 0.93 KDM4E (0.60) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL7141516 0.86 LMNA (0.60) SMN1; SMN2MAPTKDM4EMEN1NPC1
Propionamide SCHEMBL27520984 0.85 LMNA (0.59) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL7145890 0.84 LMNA (0.77) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL7137025 0.84 LMNA (0.57) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL10016535 0.82 SMN1; SMN2 (1.00) SMN1; SMN2MAPTKDM4EMEN1NPC1
SCHEMBL8500494 0.82 LMNA (0.55) SMN1; SMN2MAPTKDM4EMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed